EOG Resources (EOG) reported earnings 30 days ago. What's next for the stock?
Entegris (ENTG) reported earnings 30 days ago. What's next for the stock?
Fidelity National (FIS) reported earnings 30 days ago. What's next for the stock?
Expeditors International (EXPD) reported earnings 30 days ago. What's next for the stock?
Gilead (GILD) reported earnings 30 days ago. What's next for the stock?
Energy Transfer LP (ET) reported earnings 30 days ago. What's next for the stock?
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?
Harmony Biosciences (HRMY) reported earnings 30 days ago. What's next for the stock?
ImmunityBio (IBRX) reported earnings 30 days ago. What's next for the stock?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?
W.W. Grainger (GWW) reported earnings 30 days ago. What's next for the stock?
Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
Gartner (IT) reported earnings 30 days ago. What's next for the stock?
IPG (IPGP) reported earnings 30 days ago. What's next for the stock?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Kimco Realty (KIM) reported earnings 30 days ago. What's next for the stock?
Kratos (KTOS) reported earnings 30 days ago. What's next for the stock?
Jacobs Solutions (J) reported earnings 30 days ago. What's next for the stock?
Palantir just posted the kind of revenue growth that makes software investors stop mid-scroll, yet the stock sits 8% below its all-time high with insiders selling and a valuation that has skeptics reaching for antacids.
The two companies already work together to help developers use Nvidia's computing services on the platform.
Pound Sterling Price News and Forecast: GBP/USD rises as Fed's Waller tempers Fed hike bets before NFP
CNBC's Phil Le Beau joins 'Squawk on the Street' to discuss what to expect from Tesla's Cybercab event.
Strive shares climbed to a year-to-date high of $26.84 on Thursday, placing the stock less than 1% below the warrants' exercise price.
Ciena Corporation‘s (NYSE:CIEN | CIEN Price Prediction) fiscal third-quarter beat wasn't enough to save its stock this morning.
AGX's Q2 earnings and revenues beat estimates as Power growth, margin expansion and a $2.5B backlog strengthen its outlook.
Reinsurance Group is expanding underwriting opportunities, investment income and technology partnerships while balancing growth with disciplined capital returns.
Ford's F-Series production is rebounding, but weak U.S. sales, plunging EV demand and rising costs keep the stock outlook balanced.
Teva's TEV '408 meets its phase IIa celiac disease goal, preventing gluten-induced intestinal damage and showing a favorable safety profile.
VZ's cost cuts, customer-focused strategy and AI infrastructure push are fueling gains, but competition and high debt remain key concerns.